News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Covidien plc (COV) Prevails in Patent Action Against Covidien (COV)


8/30/2013 9:42:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW HAVEN, Conn.--(BUSINESS WIRE)--Covidien (NYSE: COV), a global healthcare products company, announced that it has prevailed against Applied Medical Resources, Inc. in a patent action before the United States Court of Appeals for the Federal Circuit. In May 2011, Applied Medical sued Covidien in connection with Covidien’s sale of certain trocar products. On August 27, the United States Court of Appeals for the Federal Circuit affirmed the lower court’s previous ruling that Covidien’s trocar products do not infringe Applied Medical’s patent.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES